196
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial

ORCID Icon, , , , , , , , & show all
Pages 656-663 | Received 02 Nov 2022, Accepted 27 Nov 2022, Published online: 15 Dec 2022

References

  • Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164.
  • Buisson A, Gonzalez F, Poullenot F, et al. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(8):1425–1433.
  • Nett A, Velayos F, McQuaid K. Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must. Gastrointest Endosc Clin N Am. 2014;24(3):379–392.
  • Murthy SK, Feuerstein JD, Nguyen GC, et al. AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review. Gastroenterology. 2021;161(3):1043–1051.e4.
  • Friedman S, Cheifetz AS, Farraye FA, et al. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(3):534–539. Available from: https://academic.oup.com/ibdjournal/article/19/3/534/4604725
  • Spadaccini M, Frazzoni L, Vanella G, et al. Efficacy and tolerability of high- vs low-volume split-dose bowel cleansing regimens for colonoscopy: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18(7):1454–1465.e14.
  • Manes G, Fontana P, De Nucci G, et al. Colon cleansing for colonoscopy in patients with ulcerative colitis: efficacy and acceptability of a 2-L PEG plus bisacodyl versus 4-L PEG. Inflamm Bowel Dis. 2015;21(9):2137–2144.
  • Kim ES, Kim KO, Jang BI, et al. Comparison of 4-L polyethylene glycol and 2-L polyethylene glycol plus ascorbic acid in patients with inactive ulcerative colitis. Dig Dis Sci. 2017;62(9):2489–2497.
  • Hassan C, East J, Radaelli F, et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline-update 2019. Endoscopy. 2019;51(8):775–794.
  • PROSPECTO PLEINVUE POLVO PARA SOLUCION ORAL [Internet]. [cited 2022 Feb 1]. Available from: https://cima.aemps.es/cima/dochtml/p/82959/P_82959.html
  • PROSPECTO MOVIPREP POLVO PARA SOLUCION ORAL [Internet]. [cited 2022 Feb 1]. Available from: https://cima.aemps.es/cima/dochtml/p/68125/Prospecto_68125.html
  • PROSPECTO CITRAFLEET POLVO PARA SOLUCION ORAL EN SOBRES [Internet]. [cited 2022 Feb 1]. Available from: https://cima.aemps.es/cima/dochtml/p/69539/Prospecto_69539.html
  • Bisschops R, Manning J, Clayton LB, et al. Colon cleansing efficacy and safety with 1 L NER1006 versus 2 L polyethylene glycol + ascorbate: a randomized phase 3 trial. Endoscopy. 2019;51(1):60–72.
  • Juan F D, Lapiedra CM, Alcantara F D, et al. ENSAYO CLINICO ALEATORIZADO Y CIEGO COMPARANDO PICOSULFATO SÓDICO (CITRAFLEET®) Y MACROGOL 3350 (MOVIPREP®) EN LA PREPARACIÓN PARA COLONOSCOPIA. Endoscopy. 2011;43(12):A42.
  • Schreiber S, Baumgart DC, Drenth JPH, et al. Colon cleansing efficacy and safety with 1 L NER1006 versus sodium picosulfate with magnesium citrate: a randomized phase 3 trial. Endoscopy. 2019;51(1):73–84.
  • Briot C, Faure P, Parmentier AL, et al. Efficacy, tolerability, and safety of Low-Volume bowel preparations for patients with inflammatory bowel diseases: the French multicentre CLEAN study. J Crohns Colitis. 2019;13(9):1121–1130.
  • Lai EJ, Calderwood AH, Doros G, et al. The Boston Bowel Preparation Scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69(3):620–625.
  • Calderwood AH, Jacobson BC. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc. 2010;72(4):686–692.
  • Kluge MA, Williams JL, Wu CK, et al. Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy. Gastrointest Endosc. 2018;87(3):744–751.
  • Clark BT, Protiva P, Nagar A, et al. Quantification of adequate bowel preparation for screening or surveillance colonoscopy in men. Gastroenterology. 2016;150(2):396–405.
  • Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004;60(3):334–339.
  • Marion JF, Sands BE. The SCENIC consensus statement on surveillance and management of dysplasia in inflammatory bowel disease: praise and words of caution. Gastroenterology. 2015;148(3):462–467.
  • Weir MA, Fleet JL, Vinden C, et al. Hyponatremia and sodium picosulfate bowel preparations in older adults. Am J Gastroenterol. 2014;109(5):686–694.
  • Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1–G47.
  • Megna B, Weiss J, Ley D, et al. Clear liquid diet before bowel preparation predicts successful chromoendoscopy in patients with inflammatory bowel disease. Gastrointest Endosc. 2019;89(2):373–379.e2.
  • Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ. 2015;351:h4672.
  • Hassan C, Fuccio L, Bruno M, et al. A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol. 2012;10(5):501–506.
  • Shieh T-Y, Chen M-J, Chang C-W, et al. Effect of physician-delivered patient education on the quality of bowel preparation for screening colonoscopy. Gastroenterol Res Pract. 2013;2013:570180.
  • Andrealli A, Paggi S, Amato A, et al. Educational strategies for colonoscopy bowel prep overcome barriers against split-dosing: a randomized controlled trial. United Eur Gastroenterol J. 2018;6(2):283–289.
  • Menees S, Higgins P, Korsnes S, et al. Does colonoscopy cause increased ulcerative colitis symptoms? 2006. Available from: https://academic.oup.com/ibdjournal/article/13/1/12/4644598
  • Zwas FR, Cirillo NW, El-Serag HB, et al. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc. 1996;43(5):463–466.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.